Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Musculoskeletal | Neurology | Cardiology/Vascular Diseases | Family Medicine
Disease Category: Chest Pain
Location: United States, OK

Trial Information

PROspective Multi-center Imaging Study for Evaluation of Chest Pain (PROMISE). A study to see which first step heart imaging test leads to better future outcomes 1) special CTA scanning to see heart artery structure, 2) heart stress tests to measure heart artery function.

The purpose of this study is to compare different, routinely-performed heart tests, such as exercise electrocardiogram (ECG), stress echocardiogram (echo), or stress nuclear test, and coronary computed tomography angiography (CTA), in identifying heart disease and reducing future heart problems.

Patient Inclusion Criteria:
Symptomatic subjects without known coronary artery disease (CAD) for whom a non-emergent, noninvasive cardiovascular diagnostic test for CAD is planned.

Patient Exclusion Criteria:
Diagnosed or suspected acute coronary syndrome; known coronary artery disease; other heart disease; recent cardiovascular evaluation, angio or stress tests (<12 months); unable to have a CTA due to contra-indication to radiation exposure, beta blockers or contrast agents; unable to consent or participate in follow up.

Vital Prospects Clinical Research Institute, P.C.
6565 S Yale Ave
Suite 209
Tulsa, OK 74136
Phone: (918) 392-4550
Fax: (918) 392-4551
Email: jodie.bechtel@aaicenter.net

View Map

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.